Literature DB >> 4518932

Decreased ketogenesis in von Gierke's disease (type I glycogenosis).

A Binkiewicz, B Senior.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4518932     DOI: 10.1016/s0022-3476(73)80531-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.

Authors:  Hironori Nagasaka; Ken-ichi Hirano; Akira Ohtake; Takashi Miida; Tomozumi Takatani; Kei Murayama; Tohru Yorifuji; Kunihiko Kobayashi; Masaki Kanazawa; Atsushi Ogawa; Masaki Takayanagi
Journal:  Eur J Pediatr       Date:  2007-01-06       Impact factor: 3.183

2.  Tolerance to prolonged fasting in two children with type I glycogen storage disease.

Authors:  P Labrune; J Chalas; C Baussan; M Odièvre
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.

Authors:  Julie Clar; Blandine Gri; Julien Calderaro; Marie-Christine Birling; Yann Hérault; G Peter A Smit; Gilles Mithieux; Fabienne Rajas
Journal:  Kidney Int       Date:  2014-04-09       Impact factor: 10.612

4.  Fat-derived fuels during a 24-hour fast in children.

Authors:  J I Wolfsdorf; A Sadeghi-Nejad; B Senior
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

5.  Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.

Authors:  Joanne A Hoogerland; Fabian Peeks; Brenda S Hijmans; Justina C Wolters; Sander Kooijman; Trijnie Bos; Aycha Bleeker; Theo H van Dijk; Henk Wolters; Albert Gerding; Karen van Eunen; Rick Havinga; Amanda C M Pronk; Patrick C N Rensen; Gilles Mithieux; Fabienne Rajas; Folkert Kuipers; Dirk-Jan Reijngoud; Terry G J Derks; Maaike H Oosterveer
Journal:  J Inherit Metab Dis       Date:  2021-04-07       Impact factor: 4.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.